Raras
Buscar doenças, sintomas, genes...
Doença de Dent
ORPHA:1652CID-10 · N25.8CID-11 · GB90.42DOENÇA RARA

A doença de Dent é uma doença tubular renal genética rara, caracterizada por manifestações de disfunção do túbulo proximal.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A doença de Dent é uma doença tubular renal genética rara, caracterizada por manifestações de disfunção do túbulo proximal.

Pesquisas ativas
5 ensaios
12 total registrados no ClinicalTrials.gov
Publicações científicas
235 artigos
Último publicado: 2026 Apr 6

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
250
pacientes catalogados
Início
Childhood
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: N25.8
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫘
Rins
15 sintomas
🦴
Ossos e articulações
10 sintomas
🧠
Neurológico
5 sintomas
🫃
Digestivo
2 sintomas
👁️
Olhos
1 sintomas
📏
Crescimento
1 sintomas

+ 18 sintomas em outras categorias

Características mais comuns

90%prev.
Fraturas recorrentes
Muito frequente (99-80%)
90%prev.
Doença renal crônica
Muito frequente (99-80%)
90%prev.
Hipercalciúria
Muito frequente (99-80%)
90%prev.
Fibrose túbulo-intersticial
Muito frequente (99-80%)
90%prev.
Aminoacidúria
Muito frequente (99-80%)
90%prev.
Nefrolitíase
Muito frequente (99-80%)
52sintomas
Muito frequente (20)
Frequente (4)
Ocasional (16)
Sem dados (12)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 52 características clínicas mais associadas, ordenadas por frequência.

Fraturas recorrentesRecurrent fractures
Muito frequente (99-80%)90%
Doença renal crônicaChronic kidney disease
Muito frequente (99-80%)90%
HipercalciúriaHypercalciuria
Muito frequente (99-80%)90%
Fibrose túbulo-intersticialTubulointerstitial fibrosis
Muito frequente (99-80%)90%
AminoacidúriaAminoaciduria
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico235PubMed
Últimos 10 anos187publicações
Pico202024 papers
Linha do tempo
2026Hoje · 2026🧪 2003Primeiro ensaio clínico📈 2020Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

2 genes identificados com associação a esta condição. Padrão de herança: X-linked recessive.

OCRLInositol polyphosphate 5-phosphatase OCRLDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Catalyzes the hydrolysis of the 5-position phosphate of phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) and phosphatidylinositol-3,4,5-bisphosphate (PtdIns(3,4,5)P3), with the greatest catalytic activity towards PtdIns(4,5)P2 (PubMed:10764818, PubMed:15474001, PubMed:7761412, PubMed:9430698). Able also to hydrolyze the 5-phosphate of inositol 1,4,5-trisphosphate and of inositol 1,3,4,5-tetrakisphosphate (PubMed:25869668, PubMed:7761412). Regulates traffic in the endosomal pathway by regula

LOCALIZAÇÃO

Cytoplasmic vesicle, phagosome membraneEarly endosome membraneMembrane, clathrin-coated pitCell projection, cilium, photoreceptor outer segmentCell projection, ciliumCytoplasmic vesicleEndosomeGolgi apparatus, trans-Golgi networkLysosome

VIAS BIOLÓGICAS (1)
Synthesis of IP3 and IP4 in the cytosol
MECANISMO DE DOENÇA

Lowe oculocerebrorenal syndrome

X-linked multisystem disorder affecting eyes, nervous system, and kidney. It is characterized by hydrophthalmia, cataract, intellectual disability, vitamin D-resistant rickets, aminoaciduria, and reduced ammonia production by the kidney. Ocular abnormalities include cataract, glaucoma, microphthalmos, and decreased visual acuity. Developmental delay, hypotonia, behavior abnormalities, and areflexia are also present. Renal tubular involvement is characterized by impaired reabsorption of bicarbonate, amino acids, and phosphate. Musculoskeletal abnormalities such as joint hypermobility, dislocated hips, and fractures may develop as consequences of renal tubular acidosis and hypophosphatemia. Cataract is the only significant manifestation in carriers and is detected by slit-lamp examination.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Junção
60.2 TPM
Esôfago - Muscular
56.6 TPM
Testículo
55.8 TPM
Ovário
55.0 TPM
Pituitária
48.3 TPM
OUTRAS DOENÇAS (2)
oculocerebrorenal syndromeDent disease type 2
HGNC:8108UniProt:Q01968
CLCN5H(+)/Cl(-) exchange transporter 5Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Proton-coupled chloride transporter. Functions as antiport system and exchanges chloride ions against protons (PubMed:20466723). Important for normal acidification of the endosome lumen. May play an important role in renal tubular function. The CLC channel family contains both chloride channels and proton-coupled anion transporters that exchange chloride or another anion for protons. The absence of conserved gating glutamate residues is typical for family members that function as channels (Proba

LOCALIZAÇÃO

Golgi apparatus membraneEndosome membraneCell membrane

VIAS BIOLÓGICAS (1)
Stimuli-sensing channels
MECANISMO DE DOENÇA

Hypophosphatemic rickets, X-linked recessive

A renal disease belonging to the 'Dent disease complex', a group of disorders characterized by proximal renal tubular defect, hypercalciuria, nephrocalcinosis, and renal insufficiency. The spectrum of phenotypic features is remarkably similar in the various disorders, except for differences in the severity of bone deformities and renal impairment. XLHRR patients present with rickets or osteomalacia, hypophosphatemia due to decreased renal tubular phosphate reabsorption, hypercalciuria, and low molecular weight proteinuria. Patients develop nephrocalcinosis with progressive renal failure in adulthood. Female carriers may have asymptomatic hypercalciuria or hypophosphatemia only.

VIAS REACTOME (1)
OUTRAS DOENÇAS (4)
hypophosphatemic rickets, X-linked recessivenephrolithiasis, X-linked recessive, with renal failureproteinuria, low molecular weight, with hypercalciuria and nephrocalcinosisDent disease type 1
HGNC:2023UniProt:P51795

Variantes genéticas (ClinVar)

925 variantes patogênicas registradas no ClinVar.

🧬 OCRL: NM_000276.4(OCRL):c.1354C>T (p.Gln452Ter) ()
🧬 OCRL: NM_000276.4(OCRL):c.1791C>A (p.Cys597Ter) ()
🧬 OCRL: NM_000276.4(OCRL):c.1628dup (p.Tyr543Ter) ()
🧬 OCRL: NM_000276.4(OCRL):c.2469+2T>G ()
🧬 OCRL: NM_000276.4(OCRL):c.1528C>T (p.Gln510Ter) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 357 variantes classificadas pelo ClinVar.

214
125
18
Patogênica (59.9%)
VUS (35.0%)
Benigna (5.0%)
VARIANTES MAIS SIGNIFICATIVAS
CLCN5: NC_000023.10:g.(?_49832242)_(49863888_?)del [Pathogenic]
CLCN5: NM_001127898.4(CLCN5):c.2144-2A>G [Likely pathogenic]
CLCN5: NM_001127898.4(CLCN5):c.603+1G>T [Pathogenic]
CLCN5: NM_001127898.4(CLCN5):c.1975del (p.Arg659fs) [Likely pathogenic]
CLCN5: NM_001127898.4(CLCN5):c.1799G>T (p.Gly600Val) [Pathogenic]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 31
2Fase 21
·Pré-clínico9
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 11 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Doença de Dent

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

5 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

12 ensaios clínicos encontrados, 5 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
161 papers (10 anos)
#1

Molecular Mechanisms of CLCN5 Missense Mutations in Dent Disease Type 1: A Comprehensive Computational Analysis and Clinical Correlations in a Chinese Cohort.

Journal of cellular and molecular medicine2026 Mar

Dent's disease, an X-linked recessive disorder predominantly affecting males, is characterized by nephrocalcinosis, nephrolithiasis, and a high risk of progression to end-stage renal disease. Dent's disease type 1, accounting for 60% of cases, caused by mutations in the CLCN5 gene encoding the chloride ion channel protein ClC-5, exhibits significant clinical heterogeneity and variability in disease progression. The lack of hotspot mutations poses challenges for genetic diagnosis and counselling, complicating the prediction of disease outcomes. This study systematically evaluated the functional and structural impacts of 181 CLCN5 missense mutations using computational tools, including PredictSNP, MAGPIE, and molecular dynamics simulations, to propose a robust method for improving genetic counselling and prognosis prediction. Our analysis identified mutations at the dimer interface and chloride selectivity filter as critical disruptors of ClC-5 function and stability. Notably, molecular dynamics simulations of L200R, P213L, and G512R mutations revealed that L200R significantly destabilized the protein structure. Clinical data from a multicentre cohort of Chinese patients with CLCN5 mutations corroborated our computational predictions, highlighting the essential role of helix O in ClC-5 function. By integrating bioinformatics analyses with clinical validation, this study provides molecular insights into Dent's disease heterogeneity and proposes a framework for enhancing genetic counselling and prognostic assessment for affected patients.

#2

The Significance of FGF23 and 24,25-Dihydroxyvitamin D in Dent Disease Type 1.

Clinical journal of the American Society of Nephrology : CJASN2026 Feb 27

Hypercalciuria is a prominent characteristic in Dent disease type 1 (DD1) and is associated with kidney stones and nephrocalcinosis. The objectives of this study were to assess fibroblast growth factor 23 (FGF23) and 24,25-dihydroxyvitamin D (24,25(OH)2D) in DD1 patients and investigate the effects of phosphate supplementation on urinary calcium excretion. Serum and 24-hour urine assessments from adult and pediatric DD1 patients (n=10 adults; n=9 pediatrics) were compared to adult control subjects with a history of idiopathic calcium kidney stones and hypercalciuria (n=9). Adult DD1 patients and control participants completed an oral phosphate supplementation intervention (1g/day x 14 days) with reassessment immediately following intervention. FGF23 was significantly lower in DD1 than in the control cohort (adults, p=0.006) and positively correlated with 24,25(OH)2D across all study cohorts. The concentrations of 24,25(OH)2D were low with conversion ratios (25-hydroxyvitamin D:24,25(OH)2D) exceeding the clinical reference limit for five of 10 adults and six of nine pediatric DD1 patients. The DD1 cohorts were then stratified by the 24,25(OH)2D ratio into "normal" and "low" 24,25(OH)2D. Adult DD1 patients with low 24,25(OH)2D (n=5) had lower FGF23, higher 1,25(OH)2D, greater urine calcium, and greater urine protein. Pediatric stratified data mirrored that in adults with the exception of no difference in serum 1,25(OH)2D. Phosphate supplementation was effective in decreasing urine calcium in both adult DD1 and control adult cohorts. Clinical measurement of 24,25(OH)2D is a novel and useful analysis for evaluating the severity of calcium and protein dysregulation in DD1. In addition, moderate phosphate supplementation effectively mitigates urine calcium excretion in DD1 adult patients.

#3

Ten tips on the work-up and management of CKD patients with nephrolithiasis.

Clinical kidney journal2026 Jan

Historically, the management of patients with nephrolithiasis has been primarily delivered by urologists. In recent decades nephrologists have had an increasing role in caring for these patients not only in advanced stages of chronic kidney disease (CKD) but also in the diagnosis and management of underlying systemic disease, and metabolic and genetic risk factors. Globally the burden of kidney stone disease has been increasing, with metabolic disorders strongly associated with nephrolithiasis and stone-promoting urinary risk factors, including hypercalciuria, hyperoxaluria and hypocitraturia. At a healthcare level, kidney stones account for a relatively large number of emergency department visits, while individually the impact of kidney stones and the fear of recurrence often result in loss of work and high levels of psychological distress, in addition to an increased CKD risk. Kidney stones in the context of CKD of unknown cause can be the signature of an inherited disorder such as Dent disease, primary hyperoxaluria or adenine phosphoribosyltransferase deficiency (among others). Diagnosing these diseases is imperative in the current age of new treatments (e.g. small interfering RNA therapies), to avoid further deterioration of kidney function and disease recurrence post-transplantation. We outline 10 practical tips to guide clinicians in the diagnostic evaluation and management of nephrolithiasis in CKD.

#4

Dual-Genetic Etiology in an Atypical Dent Disease Phenotype Which Combines Features of Focal Segmental Glomerulosclerosis and Ellis-Van Creveld-Like Syndrome: A Case Report.

Case reports in nephrology and dialysis2026

Dent disease (DD) is an X-linked recessive renal disorder characterized by features of incomplete Fanconi syndrome. DD varies in clinical presentation, manifesting with proteinuria alone or in combination with nephrocalcinosis/nephrolithiasis, and with or without chronic kidney disease, posing a challenge to clinical diagnosis. The genetic basis of DD is not completely known; about 25-35% of DD cases lack mutations in the disease-causing CLCN5 and OCRL genes. This case report represents a rare example of a patient initially suspected of having DD, but through whole exome sequencing (WES) was found to harbor pathogenic variants in the WT1 and EVC2 genes, suggesting a dual-genetic etiology mimicking DD. We describe a young man with a renal phenotype resembling DD associated with nephrotic syndrome, focal segmental glomerulosclerosis (FSGS), tubular microcysts, and a significant family history of kidney disease. Also present was an extrarenal phenotype with short stature, narrow chest, recurrent upper respiratory tract infections, teeth anomalies and hypertension. We identified in the WT1 gene the heterozygous ultrarare missense variant (NM_024426.6:c.1088C>T p.Thr363Met), classified as a variant of uncertain significance, and in the EVC2 gene the heterozygous nonsense variant (NM_147127.5:c.2833C>T p.Arg945Ter), classified as pathogenic. The clinical phenotype combines WT1-related FSGS with a rare tubular phenotype of Ellis-van Creveld-like syndrome (EVC). This case report provides insights into the phenotypic complexity of hereditary nephropathies and the diagnostic challenge posed by overlapping glomerular and tubular presentations. WES enabled us to expand our knowledge of the genetics of kidney diseases in adults and to reclassify the patient's nephropathy.

#5

Empagliflozin does not prevent progression of Dent's disease type 1 in a mouse model.

Experimental physiology2026 Feb

Dent's disease is a rare inherited renal disorder characterized by generalized proximal tubule dysfunction with low molecular weight proteinuria, hypercalciuria, and urinary loss of other solutes. The disease is progressive and leads to chronic kidney disease. To study the mechanisms involved in its progression, we generated a knock-in mouse model displaying a classical Dent's disease type 1 phenotype. Currently, no targeted therapy exists for Dent's disease; treatment strategies primarily aim to slow the progression of specific clinical aspects. Accordingly, empagliflozin [a sodium-glucose cotransporter 2 (SGLT2) inhibitor] known to exert nephroprotective effects and to slow down the decrease of the glomerular filtration rate in diabetic and non-diabetic patients with chronic kidney disease, was administered to the knock-in mice. We demonstrated that empagliflozin administration reduces renal and urinary levels of the marker of tubular damage, Lipocalin-2 (LCN2). However, we observed that this preventive treatment does not alleviate low molecular weight proteinuria, hypercalciuria, inflammation, renal fibrosis or the decline of the glomerular filtration rate. Overall, our findings suggest that SGLT2 inhibition with empagliflozin does not prevent the progression of Dent's disease type 1 towards chronic kidney disease.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC136 artigos no totalmostrando 183

2026

Molecular Mechanisms of CLCN5 Missense Mutations in Dent Disease Type 1: A Comprehensive Computational Analysis and Clinical Correlations in a Chinese Cohort.

Journal of cellular and molecular medicine
2025

Coexisting genetic kidney disease explains many cases of 'familial' IgA nephropathy where the proband has biopsy-confirmed mesangial IgA deposits.

Frontiers in medicine
2026

The Significance of FGF23 and 24,25-Dihydroxyvitamin D in Dent Disease Type 1.

Clinical journal of the American Society of Nephrology : CJASN
2026

Ten tips on the work-up and management of CKD patients with nephrolithiasis.

Clinical kidney journal
2026

Dual-Genetic Etiology in an Atypical Dent Disease Phenotype Which Combines Features of Focal Segmental Glomerulosclerosis and Ellis-Van Creveld-Like Syndrome: A Case Report.

Case reports in nephrology and dialysis
2025

Genetic and clinical phenotype of Dent disease in Chinese children and the etiological analysis of early - onset chronic kidney disease.

Italian journal of pediatrics
2025

Clinical variation in Lowe syndrome: what and how?

Frontiers in cell and developmental biology
2025

Three intronic variants altering RNA splicing were identified in the CLCN5 gene by minigene assay.

BMC medical genomics
2025

Long-term recombinant human growth hormone therapy in Dent's disease type 1.

Endokrynologia Polska
2025

Bioinformatics analysis of a CLCN5 geneframeshift mutation in a patient with Dent disease.

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
2025

Dent Disease 1 Presented Early with Bartter-Like Syndrome Features and Rickets: A Case Report.

Case reports in nephrology and dialysis
2026

Empagliflozin does not prevent progression of Dent's disease type 1 in a mouse model.

Experimental physiology
2025

The inositol 5-phosphatases OCRL and INPP5B: Cellular functions and roles in disease.

Biochimica et biophysica acta. Molecular and cell biology of lipids
2025

[Clinical and genetic analysis of a patient with Dent disease due to hemizygous variant of the CLCN5 gene].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2025

Comprehensive Splice Pattern Analysis for Previously Reported OCRL Splicing Variants and Their Phenotypic Contributions.

Kidney international reports
2025

Phenotypes and the Importance of Genetic Analysis in Adult Patients with Nephrolithiasis and/or Nephrocalcinosis: A Single-Center Experience.

Genes
2025

Phenotype and genotype analyses of 21 Chinese patients with Dent disease.

Journal of biomedical research
2025

Understanding Rare Kidney Stone Diseases: A Review.

American journal of kidney diseases : the official journal of the National Kidney Foundation
2025

Tubular proteinuria due to hereditary endocytic receptor disorder of the proximal tubule: Dent disease and chronic benign proteinuria.

Pediatric nephrology (Berlin, Germany)
2025

Clinical features and genetic analysis of nine Chinese children with Dent disease and identification of three novel CLCN5 and OCRL variants.

Renal failure
2025

Dent disease: clinical practice recommendations.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
2024

Case Report: Early acute kidney failure in an 11-year-old boy with Dent disease type 1.

Frontiers in pediatrics
2024

Dent's disease: case series from a single center.

The Turkish journal of pediatrics
2024

A narrative review of monogenic disorders causing nephrolithiasis and chronic kidney disease.

Nephrology (Carlton, Vic.)
2024

A Focus on the Proximal Tubule Dysfunction in Dent Disease Type 1.

Genes
2024

Pediatric Dent disease presenting with rickets and end-stage renal disease: case report and literature review.

The Journal of international medical research
2024

Gene therapy of Dent disease type 1 in newborn ClC-5 null mice for sustained transgene expression and gene therapy effects.

Gene therapy
2024

Prevalence of kidney failure in adults diagnosed with hereditary tubulopathies.

Journal of nephrology
2024

[Two cases of Dent disease type 1 with Bartter-like phenotype and literature review].

Zhonghua yi xue za zhi
2024

4-Phenylbutyric Acid Treatment Reduces Low-Molecular-Weight Proteinuria in a Clcn5 Knock-in Mouse Model for Dent Disease-1.

International journal of molecular sciences
2024

A novel transgenic mouse model highlights molecular disruptions involved in the pathogenesis of Dent disease 1.

Gene
2024

A female patient with Dent disease due to skewed X-chromosome inactivation.

Clinical kidney journal
2024

Modeling Dent Disease Type 1 in Flies.

Kidney360
2024

Clinical features and genetic analysis of 15 Chinese children with dent disease.

Renal failure
2024

Renal antiporter ClC-5 regulates collagen I/IV through the β-catenin pathway and lysosomal degradation.

Life science alliance
2023

Isolation and characterization of exosome-enriched urinary extracellular vesicles from Dent's disease type 1 Spanish patients.

Nefrologia
2024

Prenatal diagnosis of dent disease type I with a nonsense pathogenic variant in CLCN5: a case study.

BMC medical genomics
2024

Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis.

Clinical journal of the American Society of Nephrology : CJASN
2024

The Apical Endocytic-Lysosomal Apparatus in CLCN5 Mutations with Phenotypic-Genotypic Correlations in Three Cases.

International journal of molecular sciences
2024

Drosophila ClC-c Is a Homolog of Human CLC-5 and a New Model for Dent Disease Type 1.

Kidney360
2023

A Case of Hidradenitis Suppurativa in a Genetically Confirmed Lowe Syndrome Patient.

Annals of dermatology
2024

Dent disease 1-linked novel CLCN5 mutations result in aberrant location and reduced ion currents.

International journal of biological macromolecules
2023

A missense mutant of ocrl1 promotes apoptosis of tubular epithelial cells and disrupts endocytosis and the cell cycle of podocytes in Dent-2 Disease.

Cell communication and signaling : CCS
2023

Characterization of pre-mRNA Splicing Defects Caused by CLCN5 and OCRL Mutations and Identification of Novel Variants Associated with Dent Disease.

Biomedicines
2023

A novel likely pathogenic CLCN5 variant in Dent's disease.

BMC nephrology
2023

Genotypic variability in patients with clinical diagnosis of Bartter syndrome type 3.

Scientific reports
2023

Pseudo-Bartter syndrome in an infant without obvious underlying conditions: A case report.

Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology
2023

Generation of a human induced pluripotent stem cell line from a patient with dent disease.

Stem cell research
2023

The Site and Type of CLCN5 Genetic Variation Impact the Resulting Dent Disease-1 Phenotype.

Kidney international reports
2023

Research progress on renal calculus associate with inborn error of metabolism.

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
2023

[A rare tubulopathy: Dent's disease in the background of focal segmental glomerular sclerosis].

Orvosi hetilap
2023

Analysis of the ratio of urinary beta-2-microglobulin to total protein concentration in children with isolated tubulointerstitial disease.

Clinical and experimental nephrology
2023

Dent disease manifesting as nephrotic syndrome.

Intractable &amp; rare diseases research
2023

Impaired Endosome Maturation Mediates Tubular Proteinuria in Dent Disease Cell Culture and Mouse Models.

Journal of the American Society of Nephrology : JASN
2023

Hemizygous loss of function mutations in CLCN5 causing end-stage kidney disease without Dent disease phenotype.

Clinical kidney journal
2023

[Short-term efficacy of dapagliflozin in children with hereditary proteinuric kidney disease].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2023

Emerging Perspectives on the Rare Tubulopathy Dent Disease: Is Glomerular Damage a Direct Consequence of ClC-5 Dysfunction?

International journal of molecular sciences
2023

A Study on the CLCN5 Gene in Iranian Patients: A Report of Novel and Recurrent Mutations.

Nephron
2022

Prenatal ultrasound findings of X-linked congenital cataracts: case report and description of a novel variant.

American journal of translational research
2023

Dent disease presenting with nyctalopia and electroretinographic correlates of vitamin A deficiency.

American journal of ophthalmology case reports
2022

A novel CLCN5 frame shift mutation responsible for Dent disease 1: Case report.

Frontiers in pediatrics
2023

Clinical and genetic characteristics of Dent's disease type 1 in Europe.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
2022

Lentiviral vector mediated gene therapy for type I Dent disease ameliorates Dent disease-like phenotypes for three months in ClC-5 null mice.

Molecular therapy. Methods &amp; clinical development
2022

Be aware of underlying Dent disease in young boys with massive proteinuria.

Pediatrics international : official journal of the Japan Pediatric Society
2022

[Current approach to management of staghorn nephrolithiasis. Literature review. Part 2].

Urologiia (Moscow, Russia : 1999)
2022

Young Adults With Hereditary Tubular Diseases: Practical Aspects for Adult-Focused Colleagues.

Advances in chronic kidney disease
2022

Megalin, a multi-ligand endocytic receptor, and its participation in renal function and diseases: A review.

Life sciences
2022

Genetic and clinical profile of patients with hypophosphatemic rickets.

European journal of medical genetics
2022

X-Linked Kidney Disorders in Women.

Seminars in nephrology
2022

Genetic testing enables a precision medicine approach for nephrolithiasis and nephrocalcinosis in pediatrics: a single-center cohort.

Molecular genetics and genomics : MGG
2022

Dent-2 disease with a Bartter-like phenotype caused by the Asp631Glu mutation in the OCRL gene.

BMC nephrology
2022

Dent Disease Type 1: A Diagnostic Dilemma and Review.

Cureus
2022

Molecular Diagnosis of Primary Hyperoxaluria Type 1 and Distal Renal Tubular Acidosis in Moroccan Patients With Nephrolithiasis and/or Nephrocalcinosis.

Cureus
2022

Rickets guidance: part II-management.

Pediatric nephrology (Berlin, Germany)
2022

Renal Expression of CLC-5 and Megalin/Cubilin in Dent-1 Disease With Nonsense Mutations of CLCN5 Gene.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
2022

A case of Dent disease type 2 with large deletion of OCRL diagnosed after close examination of a school urinary test.

CEN case reports
2021

Comprehensive Genetic Analysis Reveals Complexity of Monogenic Urinary Stone Disease.

Kidney international reports
2021

Genotype Phenotype Correlation in Dent Disease 2 and Review of the Literature: OCRL Gene Pleiotropism or Extreme Phenotypic Variability of Lowe Syndrome?

Genes
2021

Bartter-Like Syndrome as the Initial Presentation of Dent Disease 1: A Case Report.

Frontiers in pediatrics
2022

Identification of novel OCRL isoforms associated with phenotypic differences between Dent disease-2 and Lowe syndrome.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
2021

Establishment of an induced pluripotent stem cell line (NCKDi003-A) from a patient with X-linked Dent disease (X-Dent) carrying the hemizygote mutation p. T277P (c. 829A > C) in the CLCN5 gene.

Stem cell research
2021

Auto-inhibitory intramolecular S5/S6 interaction in the TRPV6 channel regulates breast cancer cell migration and invasion.

Communications biology
2021

Urinary FABP1 is a biomarker for impaired proximal tubular protein reabsorption and is synergistically enhanced by concurrent liver injury.

The Journal of pathology
2021

A 3D Renal Proximal Tubule on Chip Model Phenocopies Lowe Syndrome and Dent II Disease Tubulopathy.

International journal of molecular sciences
2021

Novel Dent disease 1 cellular models reveal biological processes underlying ClC-5 loss-of-function.

Human molecular genetics
2021

Glomerular podocyte dysfunction in inherited renal tubular disease.

World journal of pediatrics : WJP
2021

Diversity of functional alterations of the ClC-5 exchanger in the region of the proton glutamate in patients with Dent disease 1.

Human mutation
2021

Differential diagnosis of perinatal Bartter, Bartter and Gitelman syndromes.

Clinical kidney journal
2021

Establishment of an induced pluripotent stem cell line (WMUi016-A) from a patient with X-linked Dent disease (X-Dent) carrying the hemizygote mutation p.R718* (c.2152C > T) in the CLCN5 gene.

Stem cell research
2021

[Nephrocalcinosis in children].

Nephrologie &amp; therapeutique
2021

Clinical manifestation and genetic findings in three boys with low molecular Weight Proteinuria - three case reports for exploring Dent Disease and Fanconi syndrome.

BMC nephrology
2021

Atypical presentation of Dent disease in a patient with interstitial Xp11.22 deletion.

Journal of nephrology
2021

Novel Fanconi renotubular syndromes provide insights in proximal tubule pathophysiology.

American journal of physiology. Renal physiology
2021

Small molecules restore the function of mutant CLC5 associated with Dent disease.

Journal of cellular and molecular medicine
2020

Dent Disease Type 2 as a Cause of Focal Segmental Glomerulosclerosis in a 6-Year-Old Boy: A Case Report.

Frontiers in pediatrics
2020

A young man with recurrent kidney stones and renal failure.

Clinical nephrology. Case studies
2020

From Skin to Kidneys: Cutaneous Clues of Renal Disease in Children.

Dermatology practical &amp; conceptual
2020

Making a Dent in Dent Disease.

Function (Oxford, England)
2020

The phosphoinositide 3-kinase inhibitor alpelisib restores actin organization and improves proximal tubule dysfunction in vitro and in a mouse model of Lowe syndrome and Dent disease.

Kidney international
2021

Genetics and phenotypic heterogeneity of Dent disease: the dark side of the moon.

Human genetics
2020

NonO Is a Novel Co-factor of PRDM1 and Regulates Inflammatory Response in Monocyte Derived-Dendritic Cells.

Frontiers in immunology
2020

Genetic and pathological findings in a boy with psoriasis and C3 glomerulonephritis: A case report and literature review.

Molecular genetics &amp; genomic medicine
2020

Comparison of clinical and genetic characteristics between Dent disease 1 and Dent disease 2.

Pediatric nephrology (Berlin, Germany)
2020

Onset mechanism of a female patient with Dent disease 2.

Clinical and experimental nephrology
2020

A rare case of nephrotic syndrome associated with Dent's disease: a case report.

CEN case reports
2020

Phenotypic spectrum and antialbuminuric response to angiotensin converting enzyme inhibitor and angiotensin receptor blocker therapy in pediatric Dent disease.

Molecular genetics &amp; genomic medicine
2020

Incomplete cryptic splicing by an intronic mutation of OCRL in patients with partial phenotypes of Lowe syndrome.

Journal of human genetics
2020

Case report: a Chinese girl with dent disease 1 and turner syndrome due to a hemizygous CLCN5 gene mutation and Isochromosome (Xq).

BMC nephrology
2020

Transcriptome analysis of neural progenitor cells derived from Lowe syndrome induced pluripotent stem cells: identification of candidate genes for the neurodevelopmental and eye manifestations.

Journal of neurodevelopmental disorders
2020

From protein uptake to Dent disease: An overview of the CLCN5 gene.

Gene
2021

Dent disease: classification, heterogeneity and diagnosis.

World journal of pediatrics : WJP
2020

A case of Type 1 Dent disease presenting with isolated persistent proteinuria.

Turk pediatri arsivi
2020

Etiological Profile of Nephrocalcinosis in Children from Southern India.

Indian pediatrics
2020

Functional analysis of suspected splicing variants in CLCN5 gene in Dent disease 1.

Clinical and experimental nephrology
2020

Polyclonal gammopathy in an adolescent affected by Dent disease 2 and hidradenitis suppurativa.

International journal of dermatology
2020

Genetic Analyses in Dent Disease and Characterization of CLCN5 Mutations in Kidney Biopsies.

International journal of molecular sciences
2020

Nephrocalcinosis: A Review of Monogenic Causes and Insights They Provide into This Heterogeneous Condition.

International journal of molecular sciences
2020

Cl- and H+ coupling properties and subcellular localizations of wildtype and disease-associated variants of the voltage-gated Cl-/H+ exchanger ClC-5.

The Journal of biological chemistry
2019

Clinical and genetic analysis of Dent disease with nephrotic range albuminuria in Shaanxi, China.

Science China. Life sciences
2019

A Novel CLCN5 Splice Site Mutation in a Boy with Incomplete Phenotype of Dent Disease.

Journal of pediatric genetics
2019

Lowe syndrome identified in the offspring of an oocyte donor who was an unknown carrier of a de novo mutation: a case report and review of the literature.

Journal of medical case reports
2020

Multicenter study of the clinical features and mutation gene spectrum of Chinese children with Dent disease.

Clinical genetics
2019

Living Kidney Donation in a Type 1 Dent's Disease Patient from His Mother.

Kidney &amp; blood pressure research
2019

Dent disease: A window into calcium and phosphate transport.

Journal of cellular and molecular medicine
2019

Urinary apolipoprotein AI in children with kidney disease.

Pediatric nephrology (Berlin, Germany)
2020

Prevalence of low molecular weight proteinuria and Dent disease 1 CLCN5 mutations in proteinuric cohorts.

Pediatric nephrology (Berlin, Germany)
2019

C-Terminal Fibroblast Growth Factor-23 Levels in Non-Nutritional Hypophosphatemic Rickets.

Indian journal of pediatrics
2019

Familial Xp11.22 microdeletion including SHROOM4 and CLCN5 is associated with intellectual disability, short stature, microcephaly and Dent disease: a case report.

BMC medical genomics
2019

OCRL deficiency impairs endolysosomal function in a humanized mouse model for Lowe syndrome and Dent disease.

Human molecular genetics
2018

Next-Generation Sequencing in Early Diagnosis of Dent Disease 1: Two Case Reports.

Frontiers in medicine
2018

Barttin Regulates the Subcellular Localization and Posttranslational Modification of Human Cl-/H+ Antiporter ClC-5.

Frontiers in physiology
2019

Phosphoinositides in the kidney.

Journal of lipid research
2018

Modeling the neuropsychiatric manifestations of Lowe syndrome using induced pluripotent stem cells: defective F-actin polymerization and WAVE-1 expression in neuronal cells.

Molecular autism
2018

Clinical Approach to Proximal Renal Tubular Acidosis in Children.

Advances in chronic kidney disease
2018

Severe Osteomalacia with Dent Disease Caused by a Novel Intronic Mutation of the CLCN5 gene.

Internal medicine (Tokyo, Japan)
2018

Congenital and acquired diseases related to stone formation.

Current opinion in urology
2018

Congenital chloride diarrhea needs to be distinguished from Bartter and Gitelman syndrome.

Journal of human genetics
2018

A novel CLCN5 pathogenic mutation supports Dent disease with normal endosomal acidification.

Human mutation
2018

Incidental Detection of Dent-2 Disease in an Infant with Febrile Proteinuria.

Medical principles and practice : international journal of the Kuwait University, Health Science Centre
2018

A novel mutation of Dent's disease in an 11-year-old male with nephrolithiasis and nephrocalcinosis.

Archivos argentinos de pediatria
2018

[Clinical features and genetic variants of Dent disease in 10 children].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2018

The ratio of urinary α1-microglobulin to microalbumin can be used as a diagnostic criterion for tubuloproteinuria.

Intractable &amp; rare diseases research
2018

Hypercalciuria and nephrolithiasis: Expanding the renal phenotype of Donnai-Barrow syndrome.

Clinical genetics
2018

Development of ultra-deep targeted RNA sequencing for analyzing X-chromosome inactivation in female Dent disease.

Journal of human genetics
2018

Patients affected by dent disease 2 could be predisposed to hidradenitis suppurativa.

Journal of the European Academy of Dermatology and Venereology : JEADV
2018

Identification of co-occurrence in a patient with Dent's disease and ADA2-deficiency by exome sequencing.

Gene
2017

Early Recognition and Management of Rare Kidney Stone Disorders.

Urologic nursing
2017

The first Sri Lankan family with Dent disease-1 due to a pathogenic variant in the CLCN5 gene: a case report.

BMC research notes
2017

Genetic Analysis of Dent's Disease and Functional Research of CLCN5 Mutations.

DNA and cell biology
2017

Dent disease in Poland: what we have learned so far?

International urology and nephrology
2017

The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2.

Nature reviews. Nephrology
2017

Dent disease: Same CLCN5 mutation but different phenotypes in two brothers in China.

Intractable &amp; rare diseases research
2017

Diagnosis and treatment of Dent disease in 10 Chinese boys.

Intractable &amp; rare diseases research
2017

Nanotubes, the fast track to treatment of Dent disease?

Kidney international
2017

Bone marrow transplantation improves proximal tubule dysfunction in a mouse model of Dent disease.

Kidney international
2016

Digenic mutations of human OCRL paralogs in Dent's disease type 2 associated with Chiari I malformation.

Human genome variation
2016

Dent's disease complicated by nephrotic syndrome: A case report.

Intractable &amp; rare diseases research
2017

Kidney Tubular Ablation of Ocrl/Inpp5b Phenocopies Lowe Syndrome Tubulopathy.

Journal of the American Society of Nephrology : JASN
2016

Phenotype of Dent Disease in a Cohort of Indian Children.

Indian pediatrics
2017

Receptor-Mediated Endocytosis in the Proximal Tubule.

Annual review of physiology
2016

Are filtered plasma proteins processed in the same way by the kidney?

Journal of theoretical biology
2017

Decreased urinary excretion of the ectodomain form of megalin (A-megalin) in children with OCRL gene mutations.

Pediatric nephrology (Berlin, Germany)
2017

Proteinuria in Dent disease: a review of the literature.

Pediatric nephrology (Berlin, Germany)
2017

Phenotypic variability of Dent disease in a large New Zealand kindred.

Pediatric nephrology (Berlin, Germany)
2016

Glomerular Pathology in Dent Disease and Its Association with Kidney Function.

Clinical journal of the American Society of Nephrology : CJASN
2016

Observations of a large Dent disease cohort.

Kidney international
2016

Does Dent disease remain an underrecognized cause for young boys with focal glomerulosclerosis?

Pediatrics international : official journal of the Japan Pediatric Society
2016

Dent Disease in Chinese Children and Findings from Heterozygous Mothers: Phenotypic Heterogeneity, Fetal Growth, and 10 Novel Mutations.

The Journal of pediatrics
2016

Functional and transport analyses of CLCN5 genetic changes identified in Dent disease patients.

Physiological reports
2016

A pure chloride channel mutant of CLC-5 causes Dent's disease via insufficient V-ATPase activation.

Pflugers Archiv : European journal of physiology
2016

The oculocerebrorenal syndrome of Lowe: an update.

Pediatric nephrology (Berlin, Germany)
2016

On the Origin of Urinary Renin: A Translational Approach.

Hypertension (Dallas, Tex. : 1979)
2016

[Renal hypophosphatemia:pathophysiology and treatment].

Clinical calcium
2015

[Clinical and genetic analysis of Dent disease in 4 Chinese children].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2015

Nephrolithiasis and Nephrocalcinosis in Children - Metabolic and Genetic Factors.

Pediatric endocrinology reviews : PER
2016

OCRL1 engages with the F-BAR protein pacsin 2 to promote biogenesis of membrane-trafficking intermediates.

Molecular biology of the cell
2015

Nephrolithiasis, kidney failure and bone disorders in Dent disease patients with and without CLCN5 mutations.

SpringerPlus
2016

Urine proteome analysis in Dent's disease shows high selective changes potentially involved in chronic renal damage.

Journal of proteomics
2015

Dent disease in children: diagnostic and therapeutic considerations.

Clinical nephrology
2015

Nephrotic-range Albuminuria as the presenting symptom of Dent-2 disease.

Italian journal of pediatrics
2015

Mutation Update of the CLCN5 Gene Responsible for Dent Disease 1.

Human mutation
2015

Characterization of 26 deletion CNVs reveals the frequent occurrence of micro-mutations within the breakpoint-flanking regions and frequent repair of double-strand breaks by templated insertions derived from remote genomic regions.

Human genetics
2015

Double Xp11.22 deletion including SHROOM4 and CLCN5 associated with severe psychomotor retardation and Dent disease.

Molecular cytogenetics

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Doença de Dent.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Doença de Dent

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Molecular Mechanisms of CLCN5 Missense Mutations in Dent Disease Type 1: A Comprehensive Computational Analysis and Clinical Correlations in a Chinese Cohort.
    Journal of cellular and molecular medicine· 2026· PMID 41860181mais citado
  2. The Significance of FGF23 and 24,25-Dihydroxyvitamin D in Dent Disease Type 1.
    Clinical journal of the American Society of Nephrology : CJASN· 2026· PMID 41758568mais citado
  3. Ten tips on the work-up and management of CKD patients with nephrolithiasis.
    Clinical kidney journal· 2026· PMID 41498064mais citado
  4. Dual-Genetic Etiology in an Atypical Dent Disease Phenotype Which Combines Features of Focal Segmental Glomerulosclerosis and Ellis-Van Creveld-Like Syndrome: A Case Report.
    Case reports in nephrology and dialysis· 2026· PMID 41480250mais citado
  5. Empagliflozin does not prevent progression of Dent's disease type 1 in a mouse model.
    Experimental physiology· 2026· PMID 40695482mais citado
  6. Dent Disease 1 Associated with a Rare Novel Renal Chloride Channel 5 Variant in a Chinese Family.
    DNA Cell Biol· 2026· PMID 41940461recente
  7. Coexisting genetic kidney disease explains many cases of 'familial' IgA nephropathy where the proband has biopsy-confirmed mesangial IgA deposits.
    Front Med (Lausanne)· 2025· PMID 41847665recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:1652(Orphanet)
  2. MONDO:0015612(MONDO)
  3. GARD:13105(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Artigo Wikipedia(Wikipedia)
  7. Q55999527(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Doença de Dent
Compêndio · Raras BR

Doença de Dent

ORPHA:1652 · MONDO:0015612
Prevalência
Unknown
Casos
250 casos conhecidos
Herança
X-linked recessive
CID-10
N25.8 · Outros transtornos resultantes de função renal tubular alterada
CID-11
Ensaios
5 ativos
Início
Childhood
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C1845168
EuropePMC
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades